In recent years, RNA m6A modification has emerged as an important regulator in GC tumorigenesis, with the novel m6A methyltransferase METTL16 potentially modulating tumor proliferation, metastasis, and therapy resistance through regulation of key target genes and signaling pathways. This evidence concerns the gene METTL16 and neoplasm.